We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Comesto is a peer to peer web and app based service that enables professional food buyers to purchase directly from suppliers.  They are a membership funded trading platform.  The platform gives their members access to the whole market eliminating single brochures.  Comesto offers industry buyers a complete purchasing, invoicing and scheduling management service and for suppliers their aim is to provide a simple cost effective way to increase sales.  
days to go: Expired investment: £34,970
Launched in 2017, Algarve Rock is on a mission to put Portuguese craft beer on the map with flavoursome beers that embody local ingredients. The global craft beer market is expected to reach nearly $187 billion by 2025. It has carved a niche for itself in only 18 months of its inception. The 3,000 litre Brew House associated fermentation vessels and auto bottling line allow them to produce 36,000 litres per month, readily expandable to 80,000 litres to meet growing demand. Algarve Rock was the winner of the Best Stout - Trujillo Festival 2018, Spain and is the house brewer for prestigious institutions like Quinta do Lago group and Casa do Frango restaurants in London. With the investment, the company will use 40% to open Algarve Rock-themed Brewbars and Brew kiosks, 10% in increasing exports especially to the UK and USA, 10% in strengthening brand identity, 15% in recruitment procedures, and 25% in increasing brewing capacity to cater to new markets.
days to go: Expired investment: £281,607
FLY LDN is a fitness brand that imparts sports and fitness instruction via its digital platform and its studios in central London and Fitzrovia. The company launched its video-on-demand and live-streaming fitness platform, FLY LDN Online (FLO), in September 2020. It asserts that within six months of launch, FLO scaled over 28,000 monthly views across 80+ countries with users having viewed over 2.5 million minutes of FLY LDN workouts. FLY LDN won the Men's Health 'Best Studio 2019' award and was commended at the 2018 and 2019 Tatler Gym Awards. The company has also received press coverage in publications like Women's Health, Forbes, Esquire, Elle, Vogue, GQ and Glamour. It has also partnered with brands such as DKNY and ASOS. FLY LDN aspires to become a contender in the global online fitness market that is expected to reach $59 billion by 2027. The company will use the investment to further develop additional functionality and TV apps for FLO and fund marketing campaigns to fuel growth.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £340,928
HUN Wines sources premium quality wine from Stellenbosch, South Africa, to create the UK's first Fairtrade, wine in a can. It aims to become the largest canned wine brand in the world. The company asserts that its products are fully recyclable and vegan friendly. HUN Wines claims that it is backed by industry titans including James Bailey, current Waitrose CEO, Andy Shaw, previously Brewdog Beer CEO and RedBull MD, Formula racing legend David Coulthard and RedBull executives. The company has successfully canned 300,000 units of its products consisting of flavours like Rosé, Sauvignon Blanc, and Rosé Bubbles (one of the lowest-calorie wines in the UK). It accepted its first order via a Direct-to-Consumer (DTC) site in May 2020, launched nationwide in Tesco Supermarkets in June and expanded onto the e-commerce platform, Amazon, in July. HUN Wines will use 15% of the investment towards staff expenses, 40% towards marketing, 25% towards festival activations and listings, and 20% towards New Product Development (NPD).

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £600,761
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £49,990
SaaS allowing caterers globally to ensure accuracy and efficiency with enhanced operating margins.
days to go: Expired investment: £154,540
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph